Do we need biomarkers for diabetics progressing to heart failure?

Hellenic Journal of Cardiology - Tập 59 - Trang 98-99 - 2018
Kyriakos Dimitriadis1, Costas Tsioufis1, Dimitrios Tousoulis1
1First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece

Tài liệu tham khảo

Gu, 2018, Association of hemoglobin A1c variability and the incidence of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and arterial hypertension, Hellenic J Cardiol, 59, 91, 10.1016/j.hjc.2017.08.001 Greene, 2018, Failure in cardiovascular Outcome trials of patients with Type 2 diabetes, J Am Coll Cardiol, 71, 10.1016/j.jacc.2018.01.047 Seferović, 2018, Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail, 20, 853, 10.1002/ejhf.1170 Ofstad, 2018, The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions, Heart Fail Rev, 23, 303, 10.1007/s10741-018-9685-0 Cardoso, 2018, Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study, Cardiovasc Diabetol, 17, 33, 10.1186/s12933-018-0677-0 Dungan, 2011, The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure, Diabetes Metab Res Rev, 27, 85, 10.1002/dmrr.1155 Zinman, 2015, EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes, N Engl J Med, 373, 2117, 10.1056/NEJMoa1504720 Neal, 2017, CANVAS Program Collaborative Group. Canagliflozin and cardiovascular and renal events in type 2 diabetes, N Engl J Med, 377, 644, 10.1056/NEJMoa1611925 Mancia, 2013, Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J Hypertens, 31, 1281, 10.1097/01.hjh.0000431740.32696.cc Parati, 2015, Blood pressure variability: assessment, predictive value, and potential as a therapeutic target, Curr Hypertens Rep, 17, 537, 10.1007/s11906-015-0537-1 Tsioufis, 2017, Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome, J Hypertens, 35, 1100, 10.1097/HJH.0000000000001262 Monnier, 2018, The application of simple metric in the assessment of glycaemic variability, Diabetes Metab, 10.1016/j.diabet.2018.02.008